General Articles/Commentaries
Biden wants to cure hepatitis C by 2030. These barriers have been standing in the way by PBS
2023 Poses Threats and Promises for Public Policy and Patient Advocates by Jen Laws HIV/HCV Update
Blame Payers for Only 1:3 Patients Receiving HCV Cure by Jen Laws HIV/HCV Watch
DOJ Complaint Flags HCV Drug Denials for People With Addiction by Megan Brooks Medscape
Vertical hepatitis C transmission more common than assumed, study finds by Caitlyn Stulpin infectious Disease News
Sadly Predictable: STIs & HCV Rates Rising Again by Jen Laws HIV/HCV Watch
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature
Fourth Annual State of HCV Care National Survey™ by HealthHCV
Medical Journal Articles
A National Hepatitis C Elimination Program in the United States. A Historic Opportunity by Rachael L. Fleurence, MSc, PhD and Francis S. Collins, MD, PhD JAMA March 9, 2023
Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C by Jennifer Abbasi JAMA March 9, 2023
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study by Polaris Observatory HCV Collaborators Lancet Gastroenterol Hepatol 2022 May;7(5):396-415.
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis by Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al Lancet Gastroenterol Hepatol. 2022 May;7(5):426-445.
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial by Sunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton. et al Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317
Boceprevir and telaprevir in the management of hepatitis C virus-infected patients. by Butt AA, Kanwal F. Clin Infect Dis. 2012 Jan 1;54(1):96-104
Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver Zuckerman E, Safadi R, Oren R, et al Israeli Association for the Study of the Liver.Harefuah. 2012 Dec;151(12):709-14, 719.